Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2018        Go!    
 
 
September 22, Saturday 2018 8:58 PM       

       HEADLINES: Abhilash Tomy injured as storm hits Golden Globe Race                                              Bishop discharged from hospital                                              Saradakkutty remembers nuns who stood with victim                                              Keralites salute sister Anupama                                              Bishop to be presented in court after another medical check-up                                              We did not have a choice, says ex-French President Hollande on Reliance getting Rafale offsets                                              “If church try to throw us out, we’ll face it”, say nuns                                              UN Secretary-General to visit India in October                                              US Senate committee postpones Kavanaugh hearing                                              Asia Cup: Rohit's unbeaten 83 powers India to thumping win over Bangladesh                                              Kaumudi Facebook
       SCI&TECH Next Article: Soon, you can demote group admins on WhatsApp  
       Absence of this gene can give men deadly cancer
 
         Posted on :18:33:06 Jan 18, 2018
   
A A
       Last edited on:18:33:06 Jan 18, 2018
         Tags: Absence of this gene can give men deadly canc
 

WASHINGTON DC: A study has recently revealed that men who lack a certain gene subtype may be more susceptible to treatment-resistant prostate cancer.

Researchers from Cleveland Clinic confirmed for the first time a mechanistic link between the gene HSD17B4 and deadly, aggressive prostate cancer.

The team built upon their earlier seminal work in which they discovered that a gene called HSD3B1, when altered, enables prostate tumours to evade treatment and proliferate.

They went on to show that the presence of this gene variant does in fact change treatment outcomes and overall survival in men.

Lead researcher Nima Sharifi explained that they studied a related gene, called HSD17B4.

Previous research showed that HSD17B4 encodes enzymes that inactivate androgens (male hormones).

Since androgens are essential for prostate cancer growth, inactivating them should prevent cancer advancement. But these enzymes have also been observed to be more abundant in advanced prostate cancer.

Therapy for advanced prostate cancer--called androgen deprivation therapy (ADT), or chemical castration--blocks cells' supply of androgens, which they use as fuel to grow and spread.

While ADT is successful early on, it eventually fails, allowing the cancer to progress to a lethal phase called castration-resistant prostate cancer (CRPC).

"We are hopeful that these findings will lead to more precise and effective treatments for prostate cancer", Dr. Sharifi stated.

"If men lack a specific isoform of this gene, we may be able to personalise their therapy," he explained.

To determine HSD17B4's role in the transition to CRPC, the researhers analysed its expression in tissue from patients with healthy prostates, localised prostate cancer and CRPC.

They found that HSD17B4 expression levels were relatively the same in benign and local prostate cancer tissue, but significantly reduced in CRPC tissue, suggesting that HSD17B4 does play a role in preventing progression to CRPC.

The findings indicated that only one specific isoform of HSD17B4--isoform 2--enzymatically inactivated androgens and prevented tumour growth.

Their findings suggest that lack of isoform 2 leads to advanced CRPC.

The research appeared in the journal Cell Reports.

A A
       SCI&TECH
Next Article: Soon, you can demote group admins on WhatsApp
 
 
SCI&TECH HEADLINES
Pluto should be reclassified as a planet, reveals study  
Shared responsibility essential for conserving migratory species  
Microsoft releases Speech Corpus for three Indian languages  
Facebook likely to run on 100% renewable energy by 2020  
Can brain suppress the act of revenge?  
Kerala techies launch portal to facilitate relief measures  
Here's what you may not know about H2O  
Alexa will tell you when it has done its homework  
Students recreate horrific atomic bombings of Hiroshima using VR technology  
Study discovers compounds that can reverse cell ageing  
Online interactive courses on AI in trading, first time on internet  
Apple to fix devices damaged by Japan's floods for free  
IT industry should focus on developing new technologies  
Skype adds read receipts to chats  
Mobile app for replacement of transformers in Raj  
Kashmiri students make solar boat for Dal Lake  
NASA prepares to fly probe into Sun's scorching atmosphere  
Yoga helps against non-communicable diseases: WHO  
Spironolactone can help prevent acne: Study  
Older Amazonian forests help regulate global climate  
Goal conflict linked to depressive symptoms  
A new world: Top 10 new species for 2018  
Beat the risk of frailty with healthy heart  
Twitter to hide trolls that hurl abuse: Twitter CEO  
Fortnite is finally coming to Android  
 
Do you agree with Rahul's allegation against Modi over Rafale deal?
yes
 
no
 
no opinion
 
 
 
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]kaumudi.com
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy